Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 9802026, 8 pages
http://dx.doi.org/10.1155/2016/9802026
Review Article

Endothelial Microparticles Act as Novel Diagnostic and Therapeutic Biomarkers of Diabetes and Its Complications: A Literature Review

1Guangdong Medical University, Zhanjiang, Guangdong 524001, China
2Department of Anesthesiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, China

Received 23 June 2016; Revised 28 August 2016; Accepted 19 September 2016

Academic Editor: Kazuhiko Kotani

Copyright © 2016 Fan Deng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. J. Wilkin, “The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type i as well as type II diabetes,” International Journal of Obesity, vol. 33, no. 7, pp. 716–726, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Wang, F. Wei, C. Sun, and Q. Li, “The Research of Improved Grey GM (1, 1) model to predict the postprandial glucose in Type 2 diabetes,” BioMed Research International, vol. 2016, Article ID 6837052, 6 pages, 2016. View at Publisher · View at Google Scholar
  3. L. E. León, S. Rani, M. Fernandez, M. Larico, and S. D. Calligaris, “Subclinical detection of diabetic cardiomyopathy with microRNAs: challenges and perspectives,” Journal of Diabetes Research, vol. 2016, Article ID 6143129, 12 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Kagota, K. Maruyama, and J. J. McGuire, “Characterization and functions of protease-activated receptor 2 in obesity, diabetes, and metabolic syndrome: a systematic review,” BioMed Research International, vol. 2016, Article ID 3130496, 16 pages, 2016. View at Publisher · View at Google Scholar
  5. S. M. Aurelian, D. M. Cheţa, and D. Onicescu, “Microvesicles-potential biomarkers for the interrelations atherosclerosis/type 2 diabetes mellitus,” Romanian Journal of Morphology and Embryology, vol. 55, pp. 1035–1039, 2014. View at Google Scholar · View at Scopus
  6. H. Koga, S. Sugiyama, K. Kugiyama et al., “Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease,” Journal of the American College of Cardiology, vol. 45, no. 10, pp. 1622–1630, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Kotani and T. Yamada, “Association between urinary 8-OHdG and pulse wave velocity in hypertensive patients with type 2 diabetes mellitus,” Singapore Medical Journal, vol. 55, no. 4, pp. 202–208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Nomura, N. Inami, A. Shouzu, F. Urase, and Y. Maeda, “Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus,” Platelets, vol. 20, no. 6, pp. 406–414, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Alexandru, E. Badila, E. Weiss, D. Cochior, E. Stępień, and A. Georgescu, “Vascular complications in diabetes: microparticles and microparticle associated microRNAs as active players,” Biochemical and Biophysical Research Communications, vol. 472, no. 1, pp. 1–10, 2016. View at Publisher · View at Google Scholar
  10. M. Kozakova and C. Palombo, “Diabetes mellitus, Arterialwall, and cardiovascular risk assessment,” International Journal of Environmental Research and Public Health, vol. 13, no. 2, article 201, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Kotani, “Plasma lipoprotein-associated phospholipase A2 levels correlated with the cardio-ankle vascular index in long-term type 2 diabetes mellitus patients,” International Journal of Molecular Sciences, vol. 17, no. 5, article 634, 2016. View at Publisher · View at Google Scholar
  12. Z. Mallat, H. Benamer, B. Hugel et al., “Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes,” Circulation, vol. 101, no. 8, pp. 841–843, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Wan, L. Yu, J. Cheng et al., “Circulating endothelial microparticles and correlation of serum 1,25-dihydroxyvitamin D with Adiponectin, nonesterified fatty acids, and glycerol from middle-aged men in China,” BioMed Research International, vol. 2016, Article ID 8420768, 5 pages, 2016. View at Publisher · View at Google Scholar
  14. A. Agouni, R. Andriantsitohaina, and M. C. Martinez, “Microparticles as biomarkers of vascular dysfunction in metabolic syndrome and its individual components,” Current Vascular Pharmacology, vol. 12, no. 3, pp. 483–492, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Dignat-George and C. M. Boulanger, “The many faces of endothelial microparticles,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 1, pp. 27–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Sabatier, P. Darmon, B. Hugel et al., “Type 1 and type 2 diabetic patients display different patterns of cellular microparticles,” Diabetes, vol. 51, no. 9, pp. 2840–2845, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Bernard, R. Loffroy, A. Sérusclat et al., “Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT),” Atherosclerosis, vol. 203, no. 2, pp. 429–435, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Chen, S. Chen, Y. Chen et al., “Circulating endothelial progenitor cells and cellular membrane microparticles in db/db diabetic mouse: possible implications in cerebral ischemic damage,” American Journal of Physiology—Endocrinology and Metabolism, vol. 301, no. 1, pp. E62–E71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Markiewicz, E. Richard, N. Marks, and A. Ludwicka-Bradley, “Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases,” Journal of Aging Research, vol. 2013, Article ID 734509, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. A. F. Tramontano, R. Lyubarova, J. Tsiakos, T. Palaia, J. R. Deleon, and L. Ragolia, “Circulating endothelial microparticles in diabetes mellitus,” Mediators of Inflammation, vol. 2010, Article ID 250476, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Esposito, M. Ciotola, F. Giugliano et al., “Endothelial microparticles correlate with erectile dysfunction in diabetic men,” International Journal of Impotence Research, vol. 19, no. 2, pp. 161–166, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. E. Berezin, A. A. Kremzer, T. A. Samura, T. A. Berezina, and P. Kruzliak, “Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus,” Journal of Endocrinological Investigation, vol. 38, no. 8, pp. 865–874, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. A. S. Leroyer, H. Isobe, G. Lesèche et al., “Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques,” Journal of the American College of Cardiology, vol. 49, no. 7, pp. 772–777, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Combes, A.-C. Simon, G.-E. Grau et al., “In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant,” The Journal of Clinical Investigation, vol. 104, no. 1, pp. 93–102, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. P. J. A. Yong, C. H. Koh, and W. S. N. Shim, “Endothelial microparticles: missing link in endothelial dysfunction?” European Journal of Preventive Cardiology, vol. 20, no. 3, pp. 496–512, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Schiro, F. L. Wilkinson, R. Weston, J. V. Smyth, F. Serracino-Inglott, and M. Y. Alexander, “Endothelial microparticles as conveyors of information in atherosclerotic disease,” Atherosclerosis, vol. 234, no. 2, pp. 295–302, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. A. S. Leroyer, A. Tedgui, and C. M. Boulanger, “Microparticles and type 2 diabetes,” Diabetes & Metabolism, vol. 34, no. 1, pp. 27–32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Jansen, H. Wang, D. Przybilla et al., “Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus,” Cardiovascular Diabetology, vol. 15, article 49, 2016. View at Publisher · View at Google Scholar
  29. B. Feng, Y. Chen, Y. Luo, M. Chen, X. Li, and Y. Ni, “Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus,” Atherosclerosis, vol. 208, no. 1, pp. 264–269, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Tsimerman, A. Roguin, A. Bachar, E. Melamed, B. Brenner, and A. Aharon, “Involvement of microparticles in diabetic vascular complications,” Thrombosis and Haemostasis, vol. 106, no. 2, pp. 310–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. O. Morel, B. Hugel, L. Jesel et al., “Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus,” Thrombosis and Haemostasis, vol. 91, no. 2, pp. 345–353, 2004. View at Google Scholar · View at Scopus
  32. A. Tripodi, A. Branchi, V. Chantarangkul et al., “Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay,” Journal of Thrombosis and Thrombolysis, vol. 31, no. 2, pp. 165–172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. O. Morel, L. Jesel, B. Hugel et al., “Protective effects of vitamin C on endothelium damage and platelet activation during myocardial infarction in patients with sustained generation of circulating microparticles,” Journal of Thrombosis and Haemostasis, vol. 1, no. 1, pp. 171–177, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Esposito, M. I. Maiorino, C. Di Palo et al., “Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes-a randomized controlled trial,” Diabetes, Obesity and Metabolism, vol. 13, no. 5, pp. 439–445, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Wang, L.-M. Chen, and M.-L. Liu, “Microvesicles and diabetic complications—novel mediators, potential biomarkers and therapeutic targets,” Acta Pharmacologica Sinica, vol. 35, no. 4, pp. 433–443, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Taraboletti, S. D'Ascenzo, P. Borsotti, R. Giavazzi, A. Pavan, and V. Dolo, “Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells,” American Journal of Pathology, vol. 160, no. 2, pp. 673–680, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Mezentsev, R. M. H. Merks, E. O'Riordan et al., “Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 289, no. 3, pp. H1106–H1114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Chen, B. Feng, X. Li, Y. Ni, and Y. Luo, “Plasma endothelial microparticles and their correlation with the presence of hypertension and arterial stiffness in patients with type 2 diabetes,” Journal of Clinical Hypertension, vol. 14, no. 7, pp. 455–460, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Bernal-Mizrachi, W. Jy, C. Fierro et al., “Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes,” International Journal of Cardiology, vol. 97, no. 3, pp. 439–446, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. K.-H. Jung, K. Chu, S.-T. Lee et al., “Risk of macrovascular complications in type 2 diabetes mellitus: endothelial microparticle profiles,” Cerebrovascular Diseases, vol. 31, no. 5, pp. 485–493, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Shi, S. Jiang, D. Qiu et al., “Rapid identification of potential drugs for diabetic nephropathy using whole-genome expression profiles of glomeruli,” BioMed Research International, vol. 2016, Article ID 1634730, 13 pages, 2016. View at Publisher · View at Google Scholar
  42. M. S. Williams, H. L. Rogers, N.-Y. Wang, and R. C. Ziegelstein, “Do platelet-derived microparticles play a role in depression, inflammation, and acute coronary syndrome?” Psychosomatics, vol. 55, no. 3, pp. 252–260, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. M. I. Nawaz, M. Abouammoh, H. A. Khan, A. S. Alhomida, M. F. Alfaran, and M. S. Ola, “Novel drugs and their targets in the potential treatment of diabetic retinopathy,” Medical Science Monitor, vol. 19, no. 1, pp. 300–308, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Al-Shabrawey, W. Zhang, and D. McDonald, “Diabetic retinopathy: mechanism, diagnosis, prevention, and treatment,” BioMed Research International, vol. 2015, Article ID 854593, 2 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Chahed, A. S. Leroyer, M. Benzerroug et al., “Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation,” Diabetes, vol. 59, no. 3, pp. 694–701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Esposito, M. Ciotola, F. Giugliano et al., “Phenotypic assessment of endothelial microparticles in diabetic and nondiabetic men with erectile dysfunction,” Journal of Sexual Medicine, vol. 5, no. 6, pp. 1436–1442, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Diehl, A. Fricke, L. Sander et al., “Microparticles: major transport vehicles for distinct microRNAs in circulation,” Cardiovascular Research, vol. 93, no. 4, pp. 633–644, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. G. Müller, “Microvesicles/exosomes as potential novel biomarkers of metabolic diseases,” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 5, pp. 247–282, 2012. View at Google Scholar · View at Scopus
  49. A. Zampetaki, S. Kiechl, I. Drozdov et al., “Plasma MicroRNA profiling reveals loss of endothelial MiR-126 and other MicroRNAs in type 2 diabetes,” Circulation Research, vol. 107, no. 6, pp. 810–817, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Nomura, N. Inami, Y. Kimura et al., “Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus,” Journal of Human Hypertension, vol. 21, no. 1, pp. 38–44, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Nomura, A. Shouzu, S. Omoto, M. Nishikawa, S. Fukuhara, and T. Iwasaka, “Losartan and simvastatin inhibit platelet activation in hypertensive patients,” Journal of Thrombosis and Thrombolysis, vol. 18, no. 3, pp. 177–185, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Nomura, A. Shouzu, S. Omoto et al., “Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetes,” Journal of Atherosclerosis and Thrombosis, vol. 16, no. 2, pp. 83–90, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. J.-M. Wang, Y. Wang, J.-Y. Huang et al., “C-reactive protein-induced endothelial microparticle generation in HUVECs is related to BH4-dependent NO formation,” Journal of Vascular Research, vol. 44, no. 3, pp. 241–248, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. S. H. van Ierssel, E. M. Van Craenenbroeck, V. M. Conraads et al., “Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied,” Thrombosis Research, vol. 125, no. 4, pp. 332–339, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. A. F. Tramontano, J. O'Leary, A. D. Black, R. Muniyappa, M. V. Cutaia, and N. El-Sherif, “Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway,” Biochemical and Biophysical Research Communications, vol. 320, no. 1, pp. 34–38, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. A. E. Berezin, A. A. Kremzer, T. A. Berezina, and Y. V. Martovitskaya, “The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis,” Acta Clinica Belgica, vol. 71, no. 1, pp. 38–45, 2016. View at Publisher · View at Google Scholar
  57. R. A. Malik, C. Li, W. Aziz et al., “Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy,” Journal of Cellular and Molecular Medicine, vol. 9, no. 3, pp. 692–697, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. O. Helal, C. Defoort, S. Robert et al., “Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 21, no. 9, pp. 665–671, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Agouni, A. H. Lagrue-Lak-Hal, P. H. Ducluzeau et al., “Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome,” American Journal of Pathology, vol. 173, no. 4, pp. 1210–1219, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Diamant, M. E. Tushuizen, M. N. Abid-Hussein et al., “Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent,” Thrombosis and Haemostasis, vol. 100, no. 3, pp. 489–497, 2008. View at Publisher · View at Google Scholar · View at Scopus